Published in Am J Pathol on August 21, 2009
ASS and SULT2A1 are Novel and Sensitive Biomarkers of Acute Hepatic Injury-A Comparative Study in Animal Models. J Liver (2013) 0.79
Adenosine 5'-monophosphate ameliorates D-galactosamine/lipopolysaccharide-induced liver injury through an adenosine receptor-independent mechanism in mice. Cell Death Dis (2014) 0.79
Galactose protects hepatocytes against TNF-α-induced apoptosis by promoting activation of the NF-κB signaling pathway in acute liver failure. Lab Invest (2015) 0.75
Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg (1999) 2.79
Deletion of apoptosis signal-regulating kinase 1 attenuates acetaminophen-induced liver injury by inhibiting c-Jun N-terminal kinase activation. Gastroenterology (2008) 2.70
Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells. Proc Natl Acad Sci U S A (2001) 2.12
Mechanisms of hepatic toxicity. I. TNF-induced liver injury. Am J Physiol (1998) 1.89
Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase. Hepatology (2002) 1.67
Serum transaminase elevations as indicators of hepatic injury following the administration of drugs. Regul Toxicol Pharmacol (1998) 1.58
The hepatic inflammatory response after acetaminophen overdose: role of neutrophils. Toxicol Sci (2000) 1.52
Monocyte-derived dendritic cells activated by bacteria or by bacteria-stimulated epithelial cells are functionally different. Blood (2005) 1.50
Acute liver failure. Postgrad Med J (2005) 1.42
Fructose absorption. Am J Clin Nutr (1993) 1.39
Mucosal IL-10 and TGF-beta play crucial roles in preventing LPS-driven, IFN-gamma-mediated epithelial damage in human colon explants. J Clin Invest (2008) 1.38
Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells. Hepatology (2005) 1.29
Intracellular survival pathways in the liver. Liver Int (2006) 1.26
Clinical symptomatology and management of mushroom poisoning. Toxicon (1993) 1.26
Cytokine-induced upregulation of hepatic intercellular adhesion molecule-1 messenger RNA expression and its role in the pathophysiology of murine endotoxin shock and acute liver failure. Hepatology (1995) 1.20
Intercellular adhesion molecule 1 (ICAM-1) expression and its role in neutrophil-induced ischemia-reperfusion injury in rat liver. J Leukoc Biol (1995) 1.19
Hepatoprotective effect of L-carnitine against acute acetaminophen toxicity in mice. Exp Toxicol Pathol (2007) 1.12
Peroxisome proliferator-activated receptor-gamma protects against hepatic ischemia/reperfusion injury in mice. Hepatology (2008) 1.09
Modulation of liver injury by interleukin-10. Acta Gastroenterol Belg (2003) 1.05
Effect of proinflammatory interleukins on jejunal nutrient transport. Gut (2000) 1.04
The nitric oxide donor, V-PYRRO/NO, protects against acetaminophen-induced hepatotoxicity in mice. Hepatology (2003) 1.02
Interspecies differences in acetaminophen sensitivity of human, rat, and mouse primary hepatocytes. Toxicol In Vitro (2008) 0.99
Pathophysiological mechanisms of TNF during intoxication with natural or man-made toxins. Toxicology (1999) 0.99
Acute liver failure: results of a 5-year clinical protocol. Liver Transpl Surg (1995) 0.97
Blockade of the receptor for advanced glycation end products attenuates acetaminophen-induced hepatotoxicity in mice. J Gastroenterol Hepatol (2006) 0.96
Alterations in cytokine/chemokine expression during organ-to-organ communication established via acetaminophen-induced toxicity. Exp Mol Pathol (2003) 0.91
Developmental reprogramming of rat GLUT-5 requires de novo mRNA and protein synthesis. Am J Physiol Gastrointest Liver Physiol (2001) 0.91
Hepatotoxicity of mild analgesics. Br J Clin Pharmacol (1980) 0.90
Toxins of Amanita phalloides. Toxicon (1998) 0.90
LPS/CD14 activation triggers SGLT-1-mediated glucose uptake and cell rescue in intestinal epithelial cells via early apoptotic signals upstream of caspase-3. Exp Cell Res (2006) 0.88
Sodium-dependent glucose transporter-1 as a novel immunological player in the intestinal mucosa. J Immunol (2008) 0.85
Interleukin-10 overexpression mediates phenyl-N-tert-butyl nitrone protection from endotoxemia. Shock (2002) 0.80
Free radical reactions might contribute to severe alpha amanitin hepatotoxicity--a hypothesis. Med Hypotheses (2007) 0.79
Absorption kinetics of some carbohydrates in conscious pigs. 2. Quantitative aspects. Br J Nutr (1984) 0.77
Role of HER2 in wound-induced breast carcinoma proliferation. Lancet (2003) 3.40
FOXP3 expression and overall survival in breast cancer. J Clin Oncol (2009) 2.71
Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study. Haematologica (2004) 1.72
Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease. Gastroenterology (2008) 1.62
Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study. Blood (2003) 1.62
HER2 overexpression and doxorubicin in adjuvant chemotherapy for resectable breast cancer. J Clin Oncol (2003) 1.61
Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis. Cancer Res (2008) 1.61
Apoptosis induction by trastuzumab: possible role of the core biopsy intervention. J Clin Oncol (2005) 1.49
Combination of metronomic gimatecan and CpG-oligodeoxynucleotides against an orthotopic pancreatic cancer xenograft. Cancer Biol Ther (2008) 1.47
Degranulation of paneth cells via toll-like receptor 9. Am J Pathol (2004) 1.36
Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system and dorsal root ganglia. J Histochem Cytochem (2009) 1.29
Antitumor activity of the TLR-5 ligand flagellin in mouse models of cancer. J Immunol (2006) 1.26
Activation of enteroendocrine cells via TLRs induces hormone, chemokine, and defensin secretion. J Immunol (2007) 1.15
Low molecular weight hyaluronic acid increases the self-defense of skin epithelium by induction of beta-defensin 2 via TLR2 and TLR4. J Immunol (2008) 1.14
CCN3/nephroblastoma overexpressed matricellular protein regulates integrin expression, adhesion, and dissemination in melanoma. Cancer Res (2008) 1.14
Activation of smooth muscle and myenteric plexus cells of jejunum via Toll-like receptor 4. J Cell Physiol (2006) 1.13
The product of X-linked Kallmann's syndrome gene (KAL1) affects the migratory activity of gonadotropin-releasing hormone (GnRH)-producing neurons. Hum Mol Genet (2004) 1.09
Critical role of TLR9 in acute graft-versus-host disease. J Immunol (2008) 1.03
Cardiovascular risk factors, nonalcoholic fatty liver disease, and carotid artery intima-media thickness in an adolescent population in southern Italy. Am J Epidemiol (2010) 1.02
Proximity of TPR and NTRK1 rearranging loci in human thyrocytes. Cancer Res (2005) 1.01
TLR9 agonists oppositely modulate DNA repair genes in tumor versus immune cells and enhance chemotherapy effects. Cancer Res (2011) 1.00
HER-2-positive breast carcinomas as a particular subset with peculiar clinical behaviors. Clin Cancer Res (2002) 1.00
HER2 as a target for breast cancer therapy. Expert Opin Biol Ther (2010) 0.99
CpG-oligodeoxynucleotides induce mobilization of hematopoietic progenitor cells into peripheral blood in association with mouse KC (IL-8) production. J Cell Physiol (2005) 0.97
FOXP3 expression in tumor cells and implications for cancer progression. J Cell Physiol (2013) 0.95
Therapeutic synergism of gemcitabine and CpG-oligodeoxynucleotides in an orthotopic human pancreatic carcinoma xenograft. Cancer Res (2005) 0.93
Expression profile of tyrosine phosphatases in HER2 breast cancer cells and tumors. Cell Oncol (2010) 0.93
Induction of Paneth cell degranulation by orally administered Toll-like receptor ligands. J Cell Physiol (2012) 0.93
Eradication of ovarian tumor xenografts by locoregional administration of targeted immunotherapy. Clin Cancer Res (2008) 0.93
Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses. J Leukoc Biol (2007) 0.91
The association of hepatitis B virus infection with B-cell non-Hodgkin lymphoma - a review. Am J Blood Res (2012) 0.90
Activity and resistance of trastuzumab according to different clinical settings. Cancer Treat Rev (2011) 0.90
Low dose oral administration of cytokines for treatment of allergic asthma. Pulm Pharmacol Ther (2009) 0.89
Role of proliferation in HER2 status predicted response to doxorubicin. Int J Cancer (2003) 0.89
Influence of antibiotic treatment on breast carcinoma development in proto-neu transgenic mice. Cancer Res (2006) 0.88
Peptide-mediated targeting of cytokines to tumor vasculature: the NGR-hTNF example. BioDrugs (2013) 0.88
Cross-talk among Toll-like receptors and their ligands. Int Immunol (2008) 0.86
Induction of pro-inflammatory programs in enteroendocrine cells by the Toll-like receptor agonists flagellin and bacterial LPS. Int Immunol (2008) 0.86
GM-CSF/IL-3/IL-5 receptor common beta chain (CD131) expression as a biomarker of antigen-stimulated CD8+ T cells. J Transl Med (2008) 0.86
Absence of the CD1 molecule up-regulates antitumor activity induced by CpG oligodeoxynucleotides in mice. J Immunol (2002) 0.86
Doxorubicin-induced alopecia is associated with sebaceous gland degeneration. J Invest Dermatol (2006) 0.85
Body mass index, cardiovascular risk factors, and carotid intima-media thickness in a pediatric population in southern Italy. J Pediatr Gastroenterol Nutr (2010) 0.85
Sodium-dependent glucose transporter-1 as a novel immunological player in the intestinal mucosa. J Immunol (2008) 0.85
High efficacy of CpG-ODN, cetuximab and cisplatin combination for very advanced ovarian xenograft tumors. J Transl Med (2013) 0.85
Stimulation of TLRs by LMW-HA induces self-defense mechanisms in vaginal epithelium. Immunol Cell Biol (2010) 0.85
A double-blind, randomised, vehicle-controlled clinical study to evaluate the efficacy of MAS065D in limiting the effects of radiation on the skin: interim analysis. Eur J Dermatol (2008) 0.83
Ascites regression and survival increase in mice bearing advanced-stage human ovarian carcinomas and repeatedly treated intraperitoneally with CpG-ODN. J Immunother (2010) 0.82
Thymic function and immunoglobulin mutation genotype in B-cell chronic lymphocytic leukemia patients. Int J Cancer (2003) 0.82
Receptor tyrosine kinase pathway analysis sheds light on similarities between clear-cell sarcoma and metastatic melanoma. Genes Chromosomes Cancer (2011) 0.82
microRNA levels in paraffin-embedded indolent B-cell non-Hodgkin lymphoma tissues from patients chronically infected with hepatitis B or C virus. BMC Infect Dis (2014) 0.81
Maspin influences response to doxorubicin by changing the tumor microenvironment organization. Int J Cancer (2013) 0.81
Antitumor efficacy of trastuzumab in nude mice orthotopically xenografted with human pancreatic tumor cells expressing low levels of HER-2/neu. J Immunother (2008) 0.81
Anti-tumor activity of CpG-ODN aerosol in mouse lung metastases. Int J Cancer (2013) 0.80
Approaches to improve tumor accumulation and interactions between monoclonal antibodies and immune cells. MAbs (2012) 0.80
Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study. Breast Cancer Res Treat (2011) 0.80
Enhanced antitumour efficacy of gimatecan in combination with Bcl-2 antisense oligonucleotide in human melanoma xenografts. Eur J Cancer (2005) 0.80
Increased sensitivity to chemotherapy induced by CpG-ODN treatment is mediated by microRNA modulation. PLoS One (2013) 0.79
Matured human monocyte-derived dendritic cells (MoDCs) induce expansion of CD4+CD25+FOXP3+ T cells lacking regulatory properties. Immunol Lett (2008) 0.79
EGFR through STAT3 modulates ΔN63α expression to sustain tumor-initiating cell proliferation in squamous cell carcinomas. J Cell Physiol (2013) 0.78
Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress. PLoS One (2013) 0.78
Modulation of DNA repair genes induced by TLR9 agonists: A strategy to eliminate "altered" cells? Oncoimmunology (2012) 0.78
Desmocollin 1 expression and desmosomal remodeling during terminal differentiation of human anagen hair follicle: an electron microscopic study. Exp Dermatol (2004) 0.77
Sodium glucose cotransporter 1 ligand BLF501 as a novel tool for management of gastrointestinal mucositis. Mol Cancer (2014) 0.77
CpG-Oligodeoxynucleotides activate tyrosinase-related protein 2-specific T lymphocytes but do not lead to a protective tumor-specific memory response. Cancer Immunol Immunother (2004) 0.77
Two distinct local relapse subtypes in invasive breast cancer: effect on their prognostic impact. Clin Cancer Res (2008) 0.77
Most immunoglobulin heavy chain switch mu rearrangements in B-cell chronic lymphocytic leukemia are internal deletions. FEBS Lett (2002) 0.77